Open AccessSafety and Efficacy of Bis-Glyceryl Ascorbate (Amitose DGA) to Prevent Hand-Foot Skin Reaction in Patients With Renal Cell Carcinoma Receiving Sunitinib Therapy: Protocol for a Phase I/II, Uncontrolled, Single-Arm, Open-Label Trial
Author(s) -
Kazuhiro Yamamoto,
Takeshi Ioroi,
Kenichi Harada,
Satoshi Nishiyama,
Chikako Nishigori,
Ikuko Yano
Publication year - 2019
Publication title -
jmir research protocols
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.378
H-Index - 9
ISSN - 1929-0748
DOI - 10.2196/14636
Subject(s) - sunitinib , medicine , renal cell carcinoma , ascorbic acid , adverse effect , dosing , clinical trial , surgery , oncology , chemistry , food science